Table 1 Demographic and epidemiological features of IMI-producing E. ludwigii carriers
From: A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
Variable, n (%) | ||
|---|---|---|
Age (years), mean (SD), range | 67 (18.4), 27–95 | |
Female gender | 17 (50) | |
Admission | Home residence | 31 (91.2) |
Non-elective | 27 (79.4) | |
Admitting service | Internal medicine-13 (38), General Surgery-7 (20.5), other surgical services-7 (20.5), ICU-4 (11.7), other-3 (8.8) | |
IMI-producing E. ludwigii isolation from admission (days)- range, no. within 3 days (%) | 0–76, 13 (38.2) | |
Healthcare exposure | Healthcare admission with 6 month | 24 (70.5) |
Surgery within 30 days | 12 (35.3) | |
Immunosuppression within 30 days | Chemotherapy | 1 (2.9) |
Systemic steroids | 3 (8.8) | |
Cancer | 10 (29.4) | |
Comorbidities scores, mean (SD), median | ADL1 | 83.2 (25.3), 100 |
Charlson | 4.24 (3.2), 4 | |
Invasive device within 1 week | Urine catheter | 4 (11.7) |
Central venous catheter | 0 | |
Mechanical ventilation | 4 (11.7) | |
Antimicrobial use within 30 days | Carbapenem | 2 (5.9) |
Other β-lactams | 12 (35.2) | |
Aminoglycosides | 3 (8.8) | |
Quinolones | 1 (2.9) | |
Macrolides | 1 (2.9) | |
Vancomycin | 3 (8.6) | |
Other | 4 (11.7) | |